Болезни современных технологий, или инциденталомы гипофиза (по материалам клинических рекомендаций Endocrine Society)
- Авторы: Волкова Н.И1, Антоненко М.И1
-
Учреждения:
- Ростовский ГМУ
- Выпуск: № 16 (2012)
- Страницы: 92-97
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/279940
- ID: 279940
Цитировать
Полный текст
Открытый доступ
Доступ предоставлен
Доступ платный или только для подписчиков
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
В связи с развитием визуализирующих технологий, повысилась частота выявления образований (инциденталом), которые изначально не были причиной поиска, а обнаруживались случайно при визуализирующей процедуре, которая проводится по причине, изначально не связанной с дисфункцией данного органа или подозрением на нее. В статье рассмотрены основные проблемы диагностики образований гипофиза, а также освещены последние клинические рекомендации по ведению этого состояния.
Полный текст
Список литературы
- Nammour G.M., Ybarra J., Naheedy M.H., et al. Incidental pituitary macroadenoma: a population-based study. Am J Med Sci 1997; 314:287-91.
- Feldkamp J., et al. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol (Oxf.) 1999;51:109-13.
- Oyama K., Sanno N., Tahara S., Teramoto A. Management of pituitary incidentalomas: according to a survey of pituitary inciden-talomas in Japan. Semin Ultrasound CT MR 2005;26:47-50.
- Freda P.U., et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96(4):894-904.
- Aron D.C., Howlett T.A. Pituitary incidentalomas. Endocrinol Metab Clin North Am 2000; 29:205-21.
- Johnson M., Hoare R.D., Cox T., et al. The evaluation of patients with a suspected pituitary microadenoma: computer tomography approximately magnetic resonance imaging. Clin Endocrinol (Oxford) 1992;36:335-38.
- Kulkarni M., Lee K., McArdle C., et al. MR imaging of pituitary microadenomas: technical considerations and CT correlation. Am J Neuroradiol 1988;9:5-11.
- Connor S., Penney C. MRI in the differential diagnosis of a sellar mass. Clin Radiol 2003; 58:20-31.
- Chidiac R.M., Aron D.C. Incidentalomas: a disease of modern technology. Endocrinol Metab Clin N Am 1997;26:233-53.
- Gao R., Isoda H., Tanaka T., et al. Dynamic gadolinium-enhanced MR imaging of pituitary adenomas: usefulness of sequential sagittal and coronal plane images. Eur J Radiol 2001; 39:139-46.
- Tabarin A., Perez P. Pros and cons of screening for occult Cushing syndrome. Nat Rev Endocrinol 2011;22,7(8):445-55.
- Tietz's Applied Laboratory Medicine, 2nd ed. Scott MG, Gronowski AM, Eby CS, eds. Hoboken NJ: Wiley-Interscience, a John Wiley & Sons, Inc. Publication, 2007;679.
- Molitch M.E. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am 2008;37:151-71.
- Nieman L.K., et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008;93:1526-40.
- Karavitaki N., Ansorge O., Wass J.A. Silent corticotroph adenomas. Arq Bras Endocrinol Metabol 2007;51:1314-18.
- Gruber A., Clayton J., Kumar S., et al. Pituitary apoplexy: retrospective review of 30 patients -is surgical intervention always necessary? Br J Neurosurg 2006;20:379-85.
- Arafah B.M., Kailani S.H., Nekl K.E., Gold, R.S., Selman W.R. Immediate recovery of pituitary function after transsphenoidal resection of pituitary macroadenomas. J Clin Endocrinol Metab. 79, 348-354 (1994).
- Arafah B.M. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab 1986; 62:1173-79.
- Greenman Y., Tordjman K., Osher E., et al. Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth. Clin Endocrinol (Oxf) 2005;63:39-44.
- Lohmann T., Trantakis C., Biesold M., et al. Minor tumour shrinkage in nonfunctioning pituitary adenomas by longterm treatment with the dopamine agonist cabergoline. Pituitary 2001;4:173-78.
- Pivonello R., Matrone C., Filippella M., et al. Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. J Clin Endocrinol Metab 2004;89:1674-83.
- Shomali M.E., Katznelson L. Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas. Pituitary. 5, 89-98 (2002).
- Merola B., Colao A., Ferone D., et al. Effects of a chronic treatment with octreotide in patients with functionless pituitary adenomas. Horm Res 1993;40:149-55.
- de Bruin T.W., Kwekkeboom D.J., Van't Verlaat, et al. Clinically nonfunctioning pituitary adenoma and octreotide response to long term high dose treatment, and studies in vitro. J Clin Endocrinol Metab 1992;75:1310-17.
- Colao A., DiSomma C., Pivonello R., et al. Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer 1992; 15:905-15.